FDA now requires a ll GLP-1 medications to have vision loss warning la
GLP-1

FDA now requires a ll GLP-1 medications to have vision loss warning la

NAION, non-arteritic anterior ischemic optic neuropathy, is a serious eye condition that can cause acute, painless and potentially permanent vision loss.
GLP-1 medications linked to increased risk of ischemic optic neuropahty
GLP-1

GLP-1 medications linked to increased risk of ischemic optic neuropahty

Ischemic optic neuropathy causes a sudden reduction of blood flow to the optic nerve, which can cause sudden and, in many cases, permanent partial vision loss.